Literature DB >> 9809301

Functions of the hypophysis-gonad and hypophysis-adrenal cortex systems during repeated administration of gonadotropin-releasing hormone in the postnatal period.

N P Goncharov1.   

Abstract

The effects of multiple doses of gonadotropin-releasing hormone (luliberin, LH-RH) on the functional activity of the hypophysis--gonad and hypophysis--adrenal cortex systems were studied in young hamadril baboons of different ages. After six doses (given on alternate days) of LH-RH, radioimmunoassays were used to determine blood concentrations of testosterone, dihydrotestosterone, cortisol, 11-deoxycortisol, and luteinizing hormone. A reduction in the stimulatory effect of luliberin on the luteinizing hormone level in male hamadril baboons aged one year was seen after repeated doses. There was no tendency for the stimulatory effect of LH-RH on the accompanying increase in the testosterone level to decrease. Doses of LH-RH did not alter blood cortisol levels in animals aged two years, but led to increases in cortisol in one-year-old animals. Repeated doses of LH-RH to young male hamadril baboons produced changes in adrenal steroidogenesis, with reductions in the blood corticosterone, 11-deoxycortisol, and dihydrotestosterone levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809301     DOI: 10.1007/bf02463022

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  15 in total

1.  Induction of puberty: long-term treatment with high-dose LHRH.

Authors:  C G Brook; S Dombey
Journal:  Clin Endocrinol (Oxf)       Date:  1979-07       Impact factor: 3.478

2.  Diurnal cycles in plasma FSH, testosterone and cortisol in men.

Authors:  C Faiman; J S Winter
Journal:  J Clin Endocrinol Metab       Date:  1971-08       Impact factor: 5.958

Review 3.  Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.

Authors:  S S Yen
Journal:  Fertil Steril       Date:  1983-03       Impact factor: 7.329

Review 4.  Control of adrenal androgen secretion.

Authors:  L N Parker; W D Odell
Journal:  Endocr Rev       Date:  1980       Impact factor: 19.871

5.  Long term therapy with luteinizing hormone-releasing hormone in isolated gonadotropin deficiency: failure of therapeutic response.

Authors:  D Rabin; L W McNeil
Journal:  J Clin Endocrinol Metab       Date:  1981-03       Impact factor: 5.958

6.  [Radioimmunologic method of determining 11 steroids in small samples of monkey blood plasma].

Authors:  N P Goncharov; S Chekan; A V Antonichev; G V Katsiia; V Iu Butnev
Journal:  Vopr Med Khim       Date:  1979 Jan-Feb

7.  A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.

Authors:  H L Dichek; L K Nieman; E H Oldfield; H I Pass; J D Malley; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1994-02       Impact factor: 5.958

8.  Repetitive infusion of gonadotropin-releasing hormone distinguishes hypothalamic from pituitary hypogonadism.

Authors:  P J Snyder; R S Rudenstein; D F Gardner; J G Rothman
Journal:  J Clin Endocrinol Metab       Date:  1979-05       Impact factor: 5.958

9.  Pulsatile infusion of luteinizing hormone-releasing hormone induces precocious puberty (vaginal opening and first ovulation) in the immature female guinea pig.

Authors:  M D Loose; E Terasawa
Journal:  Biol Reprod       Date:  1985-12       Impact factor: 4.285

10.  Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists.

Authors:  N Jay; M J Mansfield; R M Blizzard; W F Crowley; D Schoenfeld; L Rhubin; P A Boepple
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.